Skip To Main Content
VR Adviser on Muck Rack

VR Adviser

As seen in: ADVFN, MarketScreener
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to VR Adviser’s profile

Articles by VR Adviser

Form 8-K - Current report

|
By VHCP Management EG, VHCP Management III, VR Adviser, ized Signatory
| ADVFN
false 0001855644 0001855644 2025-04-16 2025-04-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Warrants [Member] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) Zura Bio Limited (Exact name of registrant as specified in its charter) Cayman Islands 001-40598 98-1725736 (State or other jurisdiction of incorporation)...
Open in Who Shared View Duplicates (2) Issue with article?

Form 8-K - Current report

|
By RTW Investments, VHCP Management EG, VHCP Management III, VR Adviser
| ADVFN
false 0001655759 0001655759 2023-11-24 2023-11-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 24, 2023 Arvinas, Inc.
Open in Who Shared View Duplicates (2) Issue with article?

Pharvaris N : SUBSCRIPTION AGREEMENT - Form 6-K

|
By ized Signatory, VHCP Management III, VR Adviser, VHCP Management EG
| MarketScreener
PHARVARIS N.V. (PHVS) Delayed Nasdaq - 04:00:00 2023-06-16 pm EDT 11.62 USD +4.03% 07:23a Pharvaris N : SUBSCRIPTION AGREEMENT - Form 6-K PU 06:51a Pharvaris Announces $70 Million Private Placement Financing GL 06:50a Pharvaris Announces $70 Million Private Placement Financing AQ Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco.
Open in Who Shared Issue with article?

Registration statement by foreign private issuers

|
By VHCP Management EG, VHCP Management III, VR Adviser, ized Signatory
| ADVFN
As filed with the Securities and Exchange Commission on August 16, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CASI Pharmaceuticals, Inc.
Open in Who Shared View Duplicates (3) Issue with article?
Show More